Welcome in CFDB (Cystic Fibrosis DataBase)!
This is a web-based, free access tool for health care professionals, researchers and students to evaluate in real time what are the current evidences about clinical efficacy of interventions in CF.
You'll find more than 1,300 studies divided in 8 sections, including Cochrane reviews, Cochrane protocols, DARE, HTA and Economic reviews, published RCT, published non-RCT, congress abstracts and ongoing trials.
Objective of CFDB (Cystic Fibrosis DataBase)
CFDB is a database and was ideated to classify clinical studies to get answers to specific questions:
- which interventions are effective, in which groups of CF patients and for which outcomes?
- to what extent do the results of the literature allow to make decisions for specific clinical issues? What issues need to be studied further?
This tool may help clinicians, researchers, students to have a faster updated view of clinical research in CF by using queries on the main topics in CF care. It could also be helpful to anyone going to design new studies, as it provides a concise description of what is currently known and what issues, on the contrast, need additional research.
Latest articles
Conventional chest physiotherapy compared to other airway clearance techniques for cystic fibrosis
Cochrane Database of Systematic Reviews - Cochrane Review
Details- 2023
- Main E
Psychological interventions for improving adherence to inhaled therapies in people with cystic fibrosis.
Cochrane Database of Systematic Reviews - Cochrane Protocol (ongoing review)
Details- 2023
- Dawson S
Impact of omega-3 supplementation on children and adolescents patients with cystic fibrosis: A systematic review and meta-analysis of randomized-controlled trials.
Other Reviews - Other Review
Details- 2023
- Sohouli MH
Embedded Specialist Palliative Care in Cystic Fibrosis: Results of a Randomized Feasibility Clinical Trial.
primary studies published RCT
Details- 2023
- Kavalieratos D
Heterogeneous liver on research ultrasound identifies children with cystic fibrosis at high risk of advanced liver disease.
primary studies published, non RCT
Details- 2023
- Siegel MJ
A Study to Test How Well BI 1291583 is Tolerated by People With Cystic Fibrosis Bronchiectasis (Clairaflyâ¢) - Phase 2 - Not yet recruiting
ongoing trials trial from www.clinicaltrials.gov
Details- 2023
- Boehringer Ingelheim
Comparison of two pancreatic enzyme products for exocrine insufficiency in patients with cystic fibrosis.
primary studies published RCT
Details- 2016
- Taylor CJ